SCHEMBL485471

SCHEMBL485471

c1nc2nnncc2[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30055270 0.98 ALDH1A1 (0.44)
Pyrrole SCHEMBL28968028 0.89 ALDH1A1 (0.38)
SCHEMBL29261126 0.84 ALDH1A1 (0.35)
SCHEMBL496650 0.68
SCHEMBL5170029 0.67 ALDH1A1 (0.59)
Purine SCHEMBL29703771 0.65 ALDH1A1 (0.47)
Purine SCHEMBL2120554 0.65 ALDH1A1 (0.47)
Purine SCHEMBL29365913 0.65
Purine SCHEMBL3158 0.65
SCHEMBL30110227 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516637-B1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS PLASMIA BIOTECH S L (ES) 2016-04-20 EP claimed
CN-102770532-A Thermostable biocatalyst conjugates for nucleoside synthesis PLASMIA BIOTECH S L 2012-11-07 CN claimed
EP-2516637-A1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS Plasmia Biotech, S.L. (ES) 2012-10-31 EP claimed
US-20120264175-A1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS BRILL ENGINES, S.L. (ES) 2012-10-18 US claimed
WO-2011076894-A1 THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS INSTITUT UNIV. DE CIÈNCIA I TECNOLOGIA, S.A. (ES) 2011-06-30 WO claimed
EP-2338985-A1 Thermostable biocatalyst combination for nucleoside synthesis Institut Univ. de Ciència i Tecnologia, s.a. (ES) 2011-06-29 EP claimed
US-7781189-B2 Catalyzing transglycosylation using a recombinant host cell overexpressing uridine phosphorylase and purine nucleoside phosphorylase BIO-KER S.R.L. (IT) 2010-08-24 US claimed
EP-1214331-B1 2-AZAPURINE COMPOUNDS AND THEIR USE ROCHE DIAGNOSTICS GMBH (DE) 2006-10-11 EP claimed
US-20050142645-A1 Vectors, host cells, and methods for production of uridine phosphorylase and purine nucleotide phosphorylase KERYOS SPA (IT) 2005-06-30 US claimed
EP-1141328-B1 RECOMBINANT BACTERIAL STRAINS FOR THE PRODUCTION OF NATURAL NUCLEOSIDES AND MODIFIED ANALOGUES THEREOF KERYOS SPA (IT) 2004-09-29 EP claimed
US-5478928-A Useful as antiviral agents in the treatment and prevention of AIDS SOUTHERN RESEARCH INSTITUTE (US) 1995-12-26 US claimed
WO-1995011685-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1995-05-04 WO claimed
WO-1994001117-A1 THERAPEUTIC NUCLEOSIDES THE WELLCOME FOUNDATION LIMITED (GB) 1994-01-20 WO claimed
EP-0525106-A4 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS 1993-04-21 EP claimed
EP-0491793-A4 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS 1993-03-03 EP claimed
EP-0525106-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1993-02-03 EP claimed
US-5128458-A 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 1992-07-07 US claimed
EP-0491793-A1 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1992-07-01 EP claimed
WO-1991016333-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1991-10-31 WO claimed
WO-1991004033-A1 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1991-04-04 WO claimed